PERMANENT RULES
(Board of Pharmacy)
Date of Adoption: January 8, 2003.
Purpose: The proposed rule will promote public health by improving the quality of life of persons afflicted with multiple sclerosis (MS) by allowing health care practitioners to prescribe, administer, and dispense Schedule II nonnarcotic stimulants for the purpose of treating fatigue in patients with MS.
Citation of Existing Rules Affected by this Order: Amending chapter 246-887 WAC.
Statutory Authority for Adoption: RCW 69.50.402.
Other Authority: RCW 18.64.005(7).
Adopted under notice filed as WSR 02-24-078 on December 4, 2002.
Number of Sections Adopted in Order to Comply with Federal Statute: New 0, Amended 0, Repealed 0; Federal Rules or Standards: New 0, Amended 0, Repealed 0; or Recently Enacted State Statutes: New 0, Amended 0, Repealed 0.
Number of Sections Adopted at Request of a Nongovernmental Entity: New 1, Amended 0, Repealed 0.
Number of Sections Adopted on the Agency's Own Initiative: New 0, Amended 0, Repealed 0.
Number of Sections Adopted in Order to Clarify, Streamline, or Reform Agency Procedures: New 0, Amended 0, Repealed 0.
Number of Sections Adopted Using Negotiated Rule Making:
New 0,
Amended 0,
Repealed 0;
Pilot Rule Making:
New 0,
Amended 0,
Repealed 0;
or Other Alternative Rule Making:
New 1,
Amended 0,
Repealed 0.
Effective Date of Rule:
Thirty-one days after filing.
January 15, 2003
Donna Dockter
Chair
OTS-5917.1
NEW SECTION
WAC 246-887-045
Prescribing, dispensing, or
administering of Schedule II nonnarcotic stimulants.
The
Schedule II stimulants listed in WAC 246-887-040 may be
prescribed, dispensed, or administered to patients for the
following disease states or conditions:
(1) Disease states or conditions listed in RCW 69.50.402 (3)(ii);
(2) Multiple sclerosis.
[]